Abstract:It is unclear why the ability of Zika virus (ZIKV) to cause serious disease, including Guillain-Barré syndrome and birth defects, was not recognized until recent outbreaks. One contributing factor could be genetic differences between contemporary ZIKV strains and historical ZIKV strains. All isolates from recent outbreaks encode a viral envelope protein that is glycosylated, whereas many historical ZIKV strains lack this glycosylation. We generated nonglycosylated ZIKV mutants from contemporary and historical strains and evaluated their virulence in mice. We found that nonglycosylated viruses were attenuated and produced lower viral loads in serum and brains. Our studies suggest that envelope protein glycosylation contributes to ZIKV pathogenesis, possibly by facilitating attachment to and infection of lectin-expressing leukocytes. ABSTRACT Zika virus (ZIKV) is an emerging mosquito-borne flavivirus. Recent ZIKV outbreaks have produced serious human disease, including neurodevelopmental malformations (congenital Zika syndrome) and Guillain-Barré syndrome. These outcomes were not associated with ZIKV infection prior to 2013, raising the possibility that viral genetic changes could contribute to new clinical manifestations. All contemporary ZIKV isolates encode an N-linked glycosylation site in the envelope (E) protein (N154), but this glycosylation site is absent in many historical ZIKV isolates. Here, we investigated the role of E protein glycosylation in ZIKV pathogenesis using two contemporary Asian-lineage strains (H/PF/2013 and PRVABC59) and the historical African-lineage strain (MR766). We found that glycosylated viruses were highly pathogenic in Ifnar1−/− mice. In contrast, nonglycosylated viruses were attenuated, producing lower viral loads in the serum and brain when inoculated subcutaneously but remaining neurovirulent when inoculated intracranially. These results suggest that E glycosylation is advantageous in the periphery but not within the brain. Accordingly, we found that glycosylation facilitated infection of cells expressing the lectins dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) or DC-SIGN-related (DC-SIGNR), suggesting that inefficient infection of lectin-expressing leukocytes could contribute to the attenuation of nonglycosylated ZIKV in mice. IMPORTANCE It is unclear why the ability of Zika virus (ZIKV) to cause serious disease, including Guillain-Barré syndrome and birth defects, was not recognized until recent outbreaks. One contributing factor could be genetic differences between contemporary ZIKV strains and historical ZIKV strains. All isolates from recent outbreaks encode a viral envelope protein that is glycosylated, whereas many historical ZIKV strains lack this glycosylation. We generated nonglycosylated ZIKV mutants from contemporary and historical strains and evaluated their virulence in mice. We found that nonglycosylated viruses were attenuated and produced lower viral loads in serum and brains. Our studies suggest that envelope protein glycosylation contributes to ZIKV pathogenesis, possibly by facilitating attachment to and infection of lectin-expressing leukocytes.

Neuropathogenesis of Zika Virus Infection : Potential Roles of Antibody-Mediated Pathology

The clinical spectrum and immunopathological mechanisms underlying ZIKV-induced neurological manifestations

Zika Virus Neuropathogenesis-Research and Understanding

The mechanisms of Zika virus-induced neuropathogenesis

Zika Virus—A Reemerging Neurotropic Arbovirus Associated with Adverse Pregnancy Outcomes and Neuropathogenesis

Gist of Zika Virus pathogenesis

Neurological complications of Zika virus infection

Envelope Protein Glycosylation Mediates Zika Virus Pathogenesis

Zika virus enhances monocyte adhesion and transmigration favoring viral dissemination to neural cells

Protection of ZIKV infection-induced neuropathy by abrogation of acute antiviral response in human neural progenitors

Zika virus infection disrupts neurovascular development and results in postnatal microcephaly with brain damage.

Distinct Replication Kinetics, Cytopathogenicity, and Immune Gene Regulation in Human Microglia Cells Infected with Asian and African Lineages of Zika Virus

Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection

Molecular and cellular insights into Zika virus-related neuropathies

Zika virus dysregulates the expression of astrocytic genes involved in neurodevelopment

Zika Virus Infection of Murine and Human Neutrophils and their Function as Trojan Horses to the Placenta

Zika virus tropism and pathogenesis: understanding clinical impacts and transmission dynamics

Envelope protein ubiquitination drives entry and pathogenesis of Zika virus

Host and viral mechanisms of congenital Zika syndrome

Effects of ZIKV + IgG+ complex on murine microglial cells

Zika virus replication on endothelial cells and invasion into the central nervous system by inhibiting interferon translation